Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Oral vs IV Remimazolam in Healthy Volunteers
NCT04113564Phase 1Completed
- Sponsor
- PAION AG
- Start
- Nov 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of remimazolam in Procedural sedation (PS) (2 arms), sponsored by PAION AG. Primary endpoint: Absolute oral bioavailability of remimazolam. Started Nov 2015; status: completed.
02
Drugs
remimazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT04113564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04113564.